Detalles de la búsqueda
1.
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression.
Nat Commun
; 15(1): 3732, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38702309
2.
c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction.
Endocrinology
; 149(1): 108-15, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17947357
3.
Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.
J Endocrinol
; 195(1): 95-103, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17911401
4.
Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.
Endocrinology
; 143(9): 3351-60, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12193547
5.
Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance.
J Steroid Biochem Mol Biol
; 92(3): 199-208, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15555913
6.
Regulation of gonadotropin gene expression by Mullerian inhibiting substance.
Proc Natl Acad Sci U S A
; 100(16): 9348-53, 2003 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-12878721
Resultados
1 -
6
de 6
1
Próxima >
>>